• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MELD 评分与甲状腺激素评估肝硬化预后的价值。

Evaluation of MELD Scores and Thyroid Hormones as Prognostic Factors of Liver Cirrhosis.

机构信息

Faculty of Medicine, Ovidius University of Constanta, 1 Universitatii Alley, 900470 Constanta, Romania.

"St. Apostol Andrew" Emergency County Hospital, 145 Tomis Blvd., 900591 Constanta, Romania.

出版信息

Medicina (Kaunas). 2024 Sep 9;60(9):1474. doi: 10.3390/medicina60091474.

DOI:10.3390/medicina60091474
PMID:39336515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11433705/
Abstract

: Hepatic cirrhosis is a disease with an increasing frequency globally, but its mechanisms of disease development are not yet completely known. The aim of this study was to evaluate the relationship between thyroid hormone levels (T3, fT4, and TSH) and survival in patients with chronic liver disease. : A total of 419 patients diagnosed with liver cirrhosis were included in the study. The MELD score was computed, and TSH, T3, and fT4 were collected from each patient using the ELISA procedure. Signs and symptoms of liver failure and portal hypertension confirmed the clinical diagnosis of liver cirrhosis, and biological tests and imaging methods confirmed the diagnosis. : The MELD score was positively associated with TSH on admission and TSH on discharge and negatively associated with T3 at discharge. TSH levels were higher in non-survivors than in survivors. The values of T3 and fT4 present no significant changes to be considered as prognostic factors. : Although the differences between the median TSH values of the patients who died and those who survived are not very large, the statistical significance of the data obtained demonstrates that there are changes in metabolism of the thyroid hormones during the progression of liver cirrhosis. It is possible that TSH is the one which maintains the normal balance of thyroid activity for patients with liver cirrhosis, so it can be considered as an important marker of evolution of these patients.

摘要

: 全球范围内,肝硬化的发病率呈上升趋势,但该病的发病机制尚不完全清楚。本研究旨在评估慢性肝病患者的甲状腺激素水平(T3、fT4 和 TSH)与生存率之间的关系。: 共纳入 419 例肝硬化患者。采用 ELISA 法检测每位患者的 MELD 评分、TSH、T3 和 fT4。肝衰竭和门静脉高压的体征和症状证实了肝硬化的临床诊断,而生物学检测和影像学方法则证实了诊断。: 入院时 MELD 评分与 TSH 呈正相关,与出院时 T3 呈负相关;出院时 TSH 与 MELD 评分呈正相关。与幸存者相比,非幸存者的 TSH 水平更高。T3 和 fT4 的值没有明显变化,不能作为预后因素。: 尽管死亡患者和存活患者的 TSH 中位数之间的差异不是很大,但所获得数据的统计学意义表明,在肝硬化进展过程中,甲状腺激素的代谢发生了变化。TSH 可能是维持肝硬化患者甲状腺活动正常平衡的因素,因此可以认为其是这些患者病情进展的一个重要标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/13e3fa0ae585/medicina-60-01474-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/8f26eb3d159d/medicina-60-01474-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/b03d209608ef/medicina-60-01474-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/07ce93d40d2f/medicina-60-01474-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/b6663accee11/medicina-60-01474-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/c3f277735718/medicina-60-01474-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/13e3fa0ae585/medicina-60-01474-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/8f26eb3d159d/medicina-60-01474-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/b03d209608ef/medicina-60-01474-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/07ce93d40d2f/medicina-60-01474-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/b6663accee11/medicina-60-01474-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/c3f277735718/medicina-60-01474-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd31/11433705/13e3fa0ae585/medicina-60-01474-g006.jpg

相似文献

1
Evaluation of MELD Scores and Thyroid Hormones as Prognostic Factors of Liver Cirrhosis.MELD 评分与甲状腺激素评估肝硬化预后的价值。
Medicina (Kaunas). 2024 Sep 9;60(9):1474. doi: 10.3390/medicina60091474.
2
Thyroid hormone profile is related to prognosis in acute decompensation of cirrhosis.甲状腺激素谱与肝硬化急性失代偿的预后相关。
Arch Endocrinol Metab. 2024 Aug 13;68:e230249. doi: 10.20945/2359-4292-2023-0249. eCollection 2024.
3
The influence of end-stage liver disease and liver transplantation on thyroid hormones.终末期肝病及肝移植对甲状腺激素的影响。
Arq Gastroenterol. 2015 Apr-Jun;52(2):124-8. doi: 10.1590/S0004-28032015000200009.
4
Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.肝硬化患者促甲状腺激素的昼夜变化及其与临床状态和代谢参数的关系。
Endocrine. 2015 Apr;48(3):942-8. doi: 10.1007/s12020-014-0364-1. Epub 2014 Jul 26.
5
Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acute-on-chronic liver failure.血清促甲状腺激素(TSH)作为慢性重型肝炎预后指标的价值。
Ann Hepatol. 2015 Mar-Apr;14(2):218-24.
6
Changes in thyroid function in patients with liver failure and their clinical significance: A clinical study of non-thyroidal illness syndrome in patients with liver failure.肝功能衰竭患者甲状腺功能的变化及其临床意义:肝功能衰竭患者非甲状腺疾病综合征的临床研究
Hepatobiliary Pancreat Dis Int. 2020 Dec;19(6):561-566. doi: 10.1016/j.hbpd.2020.05.001. Epub 2020 May 28.
7
[Thyroid hormones in women with liver cirrhosis].[肝硬化女性患者的甲状腺激素]
Klin Wochenschr. 1985 Aug 16;63(16):752-61. doi: 10.1007/BF01733827.
8
Chronic Liver Disease Secondary to Chronic Budd Chiari Causing Osteomalacia Leading to Pathological Fractures.继发于慢性布加综合征的慢性肝病导致骨软化症并引发病理性骨折。
J Assoc Physicians India. 2023 Jan;71(1):1.
9
Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels.围产期窒息对促甲状腺激素和甲状腺激素水平的影响。
Acta Paediatr. 2003;92(3):339-45.
10
Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy.非酒精性肝硬化合并肝性脑病患者的甲状腺功能测试
Eur J Med. 1993 Feb;2(2):83-5.

本文引用的文献

1
Liver transplantation in Latin America: reality and challenges.拉丁美洲的肝移植:现状与挑战。
Lancet Reg Health Am. 2023 Nov 18;28:100633. doi: 10.1016/j.lana.2023.100633. eCollection 2023 Dec.
2
How does alcohol use impact morbidity and mortality of liver cirrhosis? A systematic review and dose-response meta-analysis.酒精使用如何影响肝硬化的发病率和死亡率?系统评价和剂量反应荟萃分析。
Hepatol Int. 2024 Feb;18(1):216-224. doi: 10.1007/s12072-023-10584-z. Epub 2023 Sep 8.
3
Thyroid hormone action and liver disease, a complex interplay.
甲状腺激素作用与肝脏疾病:复杂的相互作用
Hepatology. 2025 Feb 1;81(2):651-669. doi: 10.1097/HEP.0000000000000551. Epub 2023 Aug 2.
4
Global burden of liver disease: 2023 update.全球肝病负担:2023 年更新。
J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
5
Global epidemiology of cirrhosis - aetiology, trends and predictions.全球肝硬化的流行病学:病因、趋势和预测。
Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28.
6
The burden of liver cirrhosis in mortality: Results from the global burden of disease study.肝硬化在死亡率中的负担:来自全球疾病负担研究的结果。
Front Public Health. 2022 Aug 11;10:909455. doi: 10.3389/fpubh.2022.909455. eCollection 2022.
7
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane.从Child-Pugh评分到终末期肝病模型(MELD)评分及其他:回顾往昔。
Ann Hepatol. 2022 Jan-Feb;27(1):100535. doi: 10.1016/j.aohep.2021.100535. Epub 2021 Sep 22.
8
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
9
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0:适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
10
Importance of thyroid-stimulating hormone levels in liver disease.甲状腺刺激激素水平在肝脏疾病中的重要性。
J Pediatr Endocrinol Metab. 2020 Sep 25;33(9):1133-1137. doi: 10.1515/jpem-2020-0031.